TickerFactsScreenerDevelopers

SUPERNUS PHARMACEUTICALS, INC. (SUPN) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$32.54M2011: -$36.19M2012: -$47.20M2013: -$57.95M2014: -$24.50M2015: $34.52M2016: $66.81M2017: $114.64M2018: $128.99M2019: $143.13M2020: $138.40M2021: $127.13M2022: $116.83M2023: $111.08M2024: $171.95M2025: $47.33M$47.33M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$47.33M-72.5%
2024$171.95M+54.8%
2023$111.08M-4.9%
2022$116.83M-8.1%
2021$127.13M-8.1%
2020$138.40M-3.3%
2019$143.13M+11.0%
2018$128.99M+12.5%
2017$114.64M+71.6%
2016$66.81M+93.5%
2015$34.52M+240.9%
2014-$24.50M+57.7%
2013-$57.95M-22.8%
2012-$47.20M-30.4%
2011-$36.19M-11.2%
2010-$32.54M—